Norethandrolone: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
No edit summary
Line 27: Line 27:
[[Category:Endocrinology]]
[[Category:Endocrinology]]


{{WikiDoc Help Menu}}
{{Refimprove|date=December 2009}}
{{WikiDoc Sources}}
{{Drugbox
| verifiedrevid = 437192948
| IUPAC_name = (17β)-17-ethyl-17-hydroxyester-4-en-3-one
| image = Norethandrolone structure.png
| width = 254
 
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|norethandrolone}}
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 
 
<!--Pharmacokinetic data-->
| bioavailability = 
| excretion = 
 
<!--Identifiers-->
| CAS_number = 52-78-8
| ATC_prefix = A14
| ATC_suffix = AA09
| PubChem = 5858
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5649
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = P7W01638W6
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07127
 
<!--Chemical data-->
| C=20 | H=30 | O=2
| molecular_weight = 302.451 g/mol
| smiles = O=C4\C=C3/[C@@H]([C@H]2CC[C@]1([C@@H](CC[C@@]1(O)CC)[C@@H]2CC3)C)CC4
| InChI = 1/C20H30O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h12,15-18,22H,3-11H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1
| InChIKey = ZDHCJEIGTNNEMY-XGXHKTLJBJ
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H30O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h12,15-18,22H,3-11H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZDHCJEIGTNNEMY-XGXHKTLJSA-N
| synonyms = <small>(8''R'',9''S'',10''R'',13''S'',14''S'',17''S'')-17-Ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[''a'']phenanthren-3-one</small>
}}
 
__NOTOC__
{{CMG}}; {{AE}} {{STY}}
 
==Overview==
 
'''Norethandrolone''' is an [[anabolic steroid]]. This drug was approved for sale by the U.S. [[Food and Drug Administration]] (FDA) in 1965 under the trade name Nilevar<ref>{{cite book|last=W.|first=Llewellyn.|title=Anabolics|year=2005|pages=156}}</ref>  and finds legitimate use as an [[androgen]] for cases of hormonal deficiency, treatment of patients with severe burns, after severe trauma and for certain forms of [[aplastic anemia]]. It is now only marketed in Australia, France and Switzerland, and as with all 17-alpha alkylated oral steroids, long-term use in high doses result in elevated liver enzymes and consequently [[cirrhosis]].<ref>{{cite book|last=D.|first=Lednicer.|title=Steroid Chemistry at Glance. Wiley.|year=2011|pages=67}}</ref>
 
==References==
{{reflist}}
 
{{Anabolic steroids}}
{{Androgenics}}
 
[[Category:Anabolic steroids]]
 
 
{{gastrointestinal-drug-stub}}

Revision as of 13:13, 11 March 2015


Norethandrolone
Clinical data
ATC code
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H30O2
Molar mass302.451 g/mol

WikiDoc Resources for Norethandrolone

Articles

Most recent articles on Norethandrolone

Most cited articles on Norethandrolone

Review articles on Norethandrolone

Articles on Norethandrolone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Norethandrolone

Images of Norethandrolone

Photos of Norethandrolone

Podcasts & MP3s on Norethandrolone

Videos on Norethandrolone

Evidence Based Medicine

Cochrane Collaboration on Norethandrolone

Bandolier on Norethandrolone

TRIP on Norethandrolone

Clinical Trials

Ongoing Trials on Norethandrolone at Clinical Trials.gov

Trial results on Norethandrolone

Clinical Trials on Norethandrolone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Norethandrolone

NICE Guidance on Norethandrolone

NHS PRODIGY Guidance

FDA on Norethandrolone

CDC on Norethandrolone

Books

Books on Norethandrolone

News

Norethandrolone in the news

Be alerted to news on Norethandrolone

News trends on Norethandrolone

Commentary

Blogs on Norethandrolone

Definitions

Definitions of Norethandrolone

Patient Resources / Community

Patient resources on Norethandrolone

Discussion groups on Norethandrolone

Patient Handouts on Norethandrolone

Directions to Hospitals Treating Norethandrolone

Risk calculators and risk factors for Norethandrolone

Healthcare Provider Resources

Symptoms of Norethandrolone

Causes & Risk Factors for Norethandrolone

Diagnostic studies for Norethandrolone

Treatment of Norethandrolone

Continuing Medical Education (CME)

CME Programs on Norethandrolone

International

Norethandrolone en Espanol

Norethandrolone en Francais

Business

Norethandrolone in the Marketplace

Patents on Norethandrolone

Experimental / Informatics

List of terms related to Norethandrolone

Norethandrolone is an anabolic steroid.

Template:Anabolic steroids

Norethandrolone
Clinical data
Synonyms(8R,9S,10R,13S,14S,17S)-17-Ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H30O2
Molar mass302.451 g/mol
3D model (JSmol)
  (verify)


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sree Teja Yelamanchili, MBBS [2]

Overview

Norethandrolone is an anabolic steroid. This drug was approved for sale by the U.S. Food and Drug Administration (FDA) in 1965 under the trade name Nilevar[1] and finds legitimate use as an androgen for cases of hormonal deficiency, treatment of patients with severe burns, after severe trauma and for certain forms of aplastic anemia. It is now only marketed in Australia, France and Switzerland, and as with all 17-alpha alkylated oral steroids, long-term use in high doses result in elevated liver enzymes and consequently cirrhosis.[2]

References

  1. W., Llewellyn. (2005). Anabolics. p. 156.
  2. D., Lednicer. (2011). Steroid Chemistry at Glance. Wiley. p. 67.

Template:Anabolic steroids


Template:Gastrointestinal-drug-stub